Skip to main content

previous disabled Page of 2
and
  1. No Access

    Living Reference Work Entry In depth

    Degenerative Glaskörpertrübungen

    Degenerative Glaskörpertrübungen (auch als Myodesopsie bezeichnet) können dauerhafte und relevante Sehbeeinträchtigungen verursachen. Mit dem Verfahren der Neodym-YAG-Laser-Vitreolyse steht ein alternative Beh...

    Steffen Schmitz-Valckenberg, Karl Brasse, Hans Hoerauf in Die Augenheilkunde

  2. Article

    Open Access

    Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study report

    This study aimed to determine the retest variability of quantitative fundus autofluorescence (QAF) in patients with and without age-related macular degeneration (AMD) and evaluate the predictive value of patie...

    Leon von der Emde, Merten Mallwitz, Marc Vaisband, Jan Hasenauer in Scientific Reports (2023)

  3. Article

    Open Access

    Blue-light fundus autofluorescence imaging of pigment epithelial detachments

    Pigment epithelial detachments (PEDs) occur in association with various chorioretinal diseases. With respect to the broad clinical spectrum of PEDs we describe fundus autofluorescence (FAF) characteristics of ...

    Almut Bindewald-Wittich, Joanna Dolar-Szczasny, Sandrine H. Kuenzel in Eye (2023)

  4. Article

    Open Access

    Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report

    Davide Garzone, Jan Henrik Terheyden, Olivier Morelle in Scientific Reports (2023)

  5. No Access

    Living Reference Work Entry In depth

    Autofluoreszenz-Imaging

    Autofluoreszenz-Imaging des Augenhintergrundes (Fundusautofluoreszenz, FAF) ist eine in-vivo-Bildgebungsmethode, die eine topografische Kartierung von natürlich oder pathologisch auftretenden intrinsischen Fluoro...

    Monika Fleckenstein, Frank G. Holz, Maximilian Pfau in Die Augenheilkunde

  6. Article

    Open Access

    Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report

    Drusen are hallmarks of early and intermediate age-related macular degeneration (AMD) but their quantification remains a challenge. We compared automated drusen volume measurements between different OCT device...

    Davide Garzone, Jan Henrik Terheyden, Olivier Morelle in Scientific Reports (2022)

  7. Article

    Open Access

    Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy

    Preservation of photoreceptors beyond areas of retinal pigment epithelium atrophy is a critical treatment goal in eyes with geographic atrophy (GA) to prevent vision loss. Thus, we assessed the association of ...

    Maximilian Pfau, Steffen Schmitz-Valckenberg, Ramiro Ribeiro in Scientific Reports (2022)

  8. Article

    Open Access

    Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report

    Quantification of the relative ellipsoid zone reflectivity (rEZR) might be a structural surrogate parameter for an early disease progression in the context of age-related macular degeneration (AMD). Within the...

    Marlene Saßmannshausen, Charlotte Behning, Ben Isselmann in Scientific Reports (2022)

  9. Article

    Open Access

    A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration—the FALCON study

    Treatment initiation with brolucizumab, a new potent anti-vascular endothelial growth factor (VEGF) agent, is typically performed with three monthly injections (loading dose) and has been well studied in treat...

    F. G. Holz, Steffen Schmitz-Valckenberg in Graefe's Archive for Clinical and Experime… (2022)

  10. Article

    Open Access

    Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence

    Refined understanding of the association of retinal microstructure with current and future (post-treatment) function in chronic central serous chorioretinopathy (cCSC) may help to identify patients that would ...

    Maximilian Pfau, Elon H. C. van Dijk, Thomas J. van Rijssen in Scientific Reports (2021)

  11. Article

    Open Access

    Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation

    To model the progression of geographic atrophy (GA) in patients with age-related macular degeneration (AMD) by building a suitable statistical regression model for GA size measurements obtained from fundus aut...

    Charlotte Behning, Monika Fleckenstein, Maximilian Pfau in BMC Medical Research Methodology (2021)

  12. Article

    Open Access

    AI-based structure-function correlation in age-related macular degeneration

    Sensitive and robust outcome measures of retinal function are pivotal for clinical trials in age-related macular degeneration (AMD). A recent development is the implementation of artificial intelligence (AI) t...

    Leon von der Emde, Maximilian Pfau, Frank G. Holz, Monika Fleckenstein in Eye (2021)

  13. Article

    Open Access

    Author Correction: Replication and Refinement of an Algorithm for Automated Drusen Segmentation on Optical Coherence Tomography

    Maximilian W. M. Wintergerst, Shekoufeh Gorgi Zadeh, Vitalis Wiens in Scientific Reports (2021)

  14. No Access

    Article

    Age-related macular degeneration

    Age-related macular degeneration (AMD) is the leading cause of legal blindness in the industrialized world. AMD is characterized by accumulation of extracellular deposits, namely drusen, along with progressive...

    Monika Fleckenstein, Tiarnán D. L. Keenan in Nature Reviews Disease Primers (2021)

  15. Article

    Open Access

    Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration

    To investigate sensitive outcome measures based exclusively on abnormal points in microperimetry testing of eyes with intermediate age-related macular degeneration (iAMD). 25 eyes of 25 subjects with iAMD had ...

    Yaniv Barkana, Susanne G. Pondorfer, Steffen Schmitz-Valckenberg in Scientific Reports (2021)

  16. No Access

    Article

    Künstliche Intelligenz in der Augenheilkunde

    Empirische Modelle sind seit Einführung der SRK(Sanders-Retzlaff-Kraff)-Formel im klinischen Alltag der Augenheilkunde etabliert. Rezente Entwicklungen im Bereich des statistischen Lernens („künstliche Intelli...

    Dr. med. Maximilian Pfau, Guenther Walther, Leon von der Emde in Der Ophthalmologe (2020)

  17. Article

    Open Access

    Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration develo** novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR

    There is an unmet need for treatment options in intermediate age-related macular degeneration (iAMD). However, for any new interventions to be tested in clinical trials, novel currently unavailable clinical en...

    Jan H. Terheyden, Frank G. Holz, Steffen Schmitz-Valckenberg, Anna Lüning in Trials (2020)

  18. Article

    Open Access

    Replication and Refinement of an Algorithm for Automated Drusen Segmentation on Optical Coherence Tomography

    Here, we investigate the extent to which re-implementing a previously published algorithm for OCT-based drusen quantification permits replicating the reported accuracy on an independent dataset. We refined tha...

    Maximilian W. M. Wintergerst, Shekoufeh Gorgi Zadeh, Vitalis Wiens in Scientific Reports (2020)

  19. No Access

    Article

    MACUSTAR: Entwicklung und klinische Validierung von funktionellen, strukturellen und patientenberichteten Endpunkten bei intermediärer altersabhängiger Makuladegeneration

    Für Therapiestudien bei intermediärer altersabhängiger Makuladegeneration (iAMD) gibt es bislang keine validierten klinischen Endpunkte.

    Jan H. Terheyden, Robert P. Finger, Steffen Schmitz-Valckenberg in Der Ophthalmologe (2019)

  20. No Access

    Article

    A classification tree approach for the modeling of competing risks in discrete time

    Cause-specific hazard models are a popular tool for the analysis of competing risks data. The classical modeling approach in discrete time consists of fitting parametric multinomial logit models. A drawback of...

    Moritz Berger, Thomas Welchowski in Advances in Data Analysis and Classificati… (2019)

previous disabled Page of 2